Efficacy and safety of Shenyankangfu Tablet, a Chinese patent medicine, for primary glomerulonephritis: A multicenter randomized controlled trialJie Wu, Xiangmei Chen, Wei Li et al.|Journal of Chinese Integrative Medicine|2021Cited by 6
Ensuring hemodialysis adequacy by dialysis dose monitoring with UV spectroscopy analysis of spent dialyzateLi Zhang, Xiangmei Chen, Wenhu Liu et al.|The International Journal of Artificial Organs|2021Cited by 3